Asbjorg Pedersen-Stray
Oslo, 0424, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
Transcriptional Profiling Shows Dampening of Interferon Gene Signatures by NAD+ Augmentation in Ataxia-Telangiectasia.
Journal: International journal of molecular sciences
Published: May 15, 2026
Unmasking immunodeficiency in sudden infant deaths: no evidence of hidden immune disorders.
Journal: Frontiers in immunology
Published: April 19, 2026
Neurological effects of encapsulated dexamethasone sodium phosphate in children aged 6-9 years with ataxia telangiectasia (NEAT): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Child & adolescent health
Published: March 11, 2026
Characterization of CTNND2-related neurodevelopmental disease, phenotype-genotype spectrum and WNT dynamics in early neurogenesis.
Journal: Research square
Published: January 08, 2026
Assessment of TREC-Based NBS SCID Reporting Practices for Harmonization of Results and Interpretation: A Global Survey.
Journal: The journal of allergy and clinical immunology. In practice
Published: November 17, 2025
The c.64 + 2 T > A Founder Variant Hits Home: Report on 14 Patients Expands the Phenotypic Landscape of Inherited ARPC1B Deficiency - a Comparative Analysis.
Journal: Clinical reviews in allergy & immunology
Published: June 05, 2025
A Norwegian cohort with STAT1-related disease - further expanding the clinical phenotype.
Journal: Frontiers in immunology
Published: April 29, 2025
Long-term safety of dexamethasone sodium phosphate encapsulated in autologous erythrocytes in pediatric patients with ataxia telangiectasia.
Journal: Frontiers in neurology
Published: November 12, 2024
A pathological missense mutation in the deubiquitinase USP5 leads to insensitivity to pain.
Journal: The Journal of experimental medicine
Published: October 10, 2024
Newborn screening for SCID and severe T lymphocytopenia in Europe.
Journal: The Journal of allergy and clinical immunology
Published: May 31, 2024
NUDCD3 deficiency disrupts V(D)J recombination to cause SCID and Omenn syndrome.
Journal: Science immunology
Published: May 24, 2024
How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms.
Journal: HemaSphere
Published: February 17, 2024
Last Updated: 09/26/2026